Filing Details
- Accession Number:
- 0001231554-11-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-24 15:17:23
- Reporting Period:
- 2011-06-22
- Filing Date:
- 2011-06-24
- Accepted Time:
- 2011-06-24 15:17:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1054833 | Coventry Health Care Inc | CVH | Hospital & Medical Service Plans (6324) | 522073000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231554 | J John Ruhlmann | 6705 Rockledge Drive Suite 900 Bethesda MD 20817 | Sr.vp And Corporate Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-06-22 | 11,250 | $32.46 | 43,352 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-06-22 | 11,250 | $36.24 | 32,102 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-06-22 | 4,000 | $20.46 | 36,102 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-06-22 | 4,000 | $36.24 | 32,102 | No | 4 | S | Direct | |
| Common Stock Restricted | Acquisiton | 2011-06-22 | 8,792 | $0.00 | 40,894 | No | 4 | A | Direct | |
| Common Stock Restricted | Disposition | 2001-06-22 | 1,758 | $36.11 | 39,136 | No | 4 | F | Direct | |
| Common Stock Restricted | Disposition | 2011-06-22 | 1,945 | $36.26 | 37,191 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option | Disposition | 2011-06-22 | 11,250 | $0.00 | 11,250 | $32.46 |
| Common Stock | Non-Qualified Stock Option | Disposition | 2011-06-22 | 4,000 | $0.00 | 4,000 | $20.46 |
| Common Stock | Non-Qualified Stock Option | Acquisiton | 2011-06-22 | 19,361 | $0.00 | 19,361 | $36.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 132,000 | 2005-06-14 | 2014-06-14 | No | 4 | M | Direct |
| 128,000 | 2011-05-26 | 2020-05-26 | No | 4 | M | Direct |
| 147,361 | 2012-06-22 | 2021-06-22 | No | 4 | A | Direct |
Footnotes
- Includes the following: Table I Non-Derivative Securities comprised of 11,250 shares of common stock held directly, 4,155 shares of common stock held indirectly by managed account (401(k) Plan), and 27,947 shares of restricted common stock with restrictions lapsed or lapsing over four-year periods, held directly.
- See Footnote 1 for shares held directly and indirectly.
- Includes the following: Table I Non-Derivative Securities comprised of 4,155 shares of common stock held indirectly by managed account (401(k) Plan), and 27,947 shares of restricted common stock with restrictions lapsed or lapsing over four-year periods, held directly.
- See Footnote 3 for shares held directly and indirectly.
- Includes the following: Table I-Non-Derivative Securities comprised of 4,000 shares of common stock held directly, 4,155 shares of common stock held indirectly by managed account (401(k) Plan), and 27,947 shares of restricted common stock with restrictions lapsed or lapsing over four-year periods, held directly.
- See Footnote 5 for shares held directly and indirectly.
- Includes the following: Table I Non-Derivative Securities comprised of 4,155 shares of common stock held indirectly by managed account (401(k) Plan), and 27,947 shares of restricted common stock with restrictions lapsed or lapsing over four-year periods, held directly.
- See Footnote 7 for shares held directly and indirectly.
- Award of performance-based restricted common stock vesting in equal annual increments over a four-year period.
- Includes the following: Table I-Non-Derivative Securities comprised of 4,155 shares of common stock held indirectly by managed account (401(k) Plan), and 36,739 shares of restricted common stock with restrictions lapsed or lapsing over four-year periods, held directly.
- See Footnote 10 for shares held directly and indirectly.
- Sale of shares back to the Company to pay withholding taxes on release of increment of restricted stock.
- Includes the following: Table I Non-Derivative Securities comprised of 4,155 shares of common stock held indirectly by managed account (401(k) Plan), and 34,981 shares of restricted common stock with restrictions lapsed or lapsing over four-year periods, held directly.
- See Footnote 13 for shares held directly and indirectly.
- Includes the following: Table I Non-Derivative Securities comprised of 4,155 shares of common stock held indirectly by managed account (401(k) Plan), and 33,036 shares of restricted common stock with restrictions lapsed or lapsing over four-year periods, held directly.
- See Footnote 15 for shares held directly and indirectly.
- Includes the following: Table II Derivative Securities consisting of non-qualified stock options for 122,000 shares of common stock vesting in equal annual increments over three- and four-year periods, held directly and 10,000 performance stock units that will be settled in cash if the award vests.
- Includes the following: Table II-Derivative Securities consisting of non-qualified stock options for 118,000 shares of common stock vesting in equal annual increments over three- and four-year periods, held directly and 10,000 performance stock units that will be settled in cash if the award vests.
- Includes the following: Table II-Derivative Securities consisting of non-qualified stock options for 137,361 shares of common stock vesting in equal annual increments over three- and four-year periods, held directly and 10,000 performance stock units that will be settled in cash if the award vests.
Billionaire Hedge Funds
